News Chart Aptamer Sciences Inc

Equities

A291650

KR7291650000

End-of-day quote Korea S.E. Other stock markets 23:00:00 18/06/2024 BST			5-day change	1st Jan Change
2,595 ^KRW	-3.89%		-10.05%	-28.02%

03-26	Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201	CI
2022	Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors	CI

c974b062cdec0fe.Dsa1PMlDlfcvlKADdQfmQa1ySdBM8Fe85EXv0CDmrCQ.QLDaa4gkosRC15lRHnCIA5gUPpp6uDDRti2flHCOyWNYteRfvyXRh2Lh7Q~c9c2632c2f1a55ed1d06f06969f655f3